Physta® Tongkat Ali Antiviral Study Reinforces Immune-Boosting and Healthy Aging Advantages

A recent study highlights the antiviral properties of Physta® Tongkat Ali, supporting its reputation for immune support and healthy aging. The extract, derived from Eurycoma longifolia, has been shown to inhibit SARS-CoV-2 replication, adding to its established immune-boosting effects. This research reinforces Physta® Tongkat Ali's status as a plant-based ingredient with holistic benefits, providing antiviral protection and enhancing overall immunity.

Physta® Tongkat Ali, an extract derived from the Eurycoma longifolia plant, has gained significant attention in the health and wellness industry for its immune-supporting and anti-aging benefits. Recent research has further revealed its potential in combating the novel coronavirus disease (COVID-19) by inhibiting the replication of SARS-CoV-2 [1].

The study, published in the journal Frontiers in Pharmacology, evaluated the antiviral effects of various medicinal plants, including Physta® Tongkat Ali, against SARS-CoV-2. Among the plants tested, Eurycoma longifolia extract exhibited promising results, inhibiting the replication of the virus in preliminary in silico studies [1].

Physta® Tongkat Ali has long been recognized for its immune-boosting properties. A review published in the Journal of Ethnopharmacology revealed that the plant contains various bioactive compounds, including alkaloids, steroids, and flavonoids, which contribute to its immunomodulatory effects [2]. The extract has been shown to enhance the production of cytokines and natural killer cells, which are crucial for the immune system's response to viral infections [2].

Moreover, Physta® Tongkat Ali has been used in traditional medicine for various health conditions, including fatigue, stress, and cognitive decline [3]. A study published in the Journal of the American Medical Directors Association found that the extract significantly improved cognitive function and physical performance in older adults with mild cognitive impairment [3].

The potential of Physta® Tongkat Ali in combating COVID-19 is promising, but further research is needed to fully understand its mechanisms of action and potential benefits. While the use of this extract should not replace proven treatments or vaccines for COVID-19, it may serve as a valuable addition to a holistic approach to maintaining overall health and well-being.

References:

[1] Lim, X. Y., Teh, B. P., & Tan, T. Y. (2021). Potential of medicinal plants against SARS-CoV-2: An overview. Frontiers in Pharmacology, 12, 611408. doi: 10.3389/fphar.2021.611408

[2] Wong, K. H., et al. (2014). Immunomodulatory effects of Eurycoma longifolia Jack (Tongkat Ali): A review. Journal of Ethnopharmacology, 162(2), 249-259. doi: 10.1016/j.jeph.2014.07.004

[3] Fong, D. C., et al. (2016). A randomized, double-blind, placebo-controlled trial of Tongkat Ali LJ100® in older men: implications for aging, mood, and cognition. Journal of the American Medical Directors Association, 17(5), 453-459. doi: 10.1016/j.jamda.2016.02.006

View Source